Quarterly report [Sections 13 or 15(d)]

Note 7 - Stock-based Compensation - Restricted Stock Transactions (Details)

v3.25.4
Note 7 - Stock-based Compensation - Restricted Stock Transactions (Details)
 3 Months Ended
Dec. 31, 2025
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Settled in Period | shares 33,834
Forfeited, weighted average grant date fair value (in dollars per share) | $ / shares $ 33.26
Unvested, number of shares (in shares) | shares 50,747
Weighted-average exercise price, outstanding (in dollars per share) | $ / shares $ 43.01
Restricted Stock [Member]  
Unvested shares, number of shares (in shares) | shares 202,185
Unvested shares, weighted average grant date fair value (in dollars per share) | $ / shares $ 27.64
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period | shares 151,170
Granted, weighted average grant date fair value (in dollars per share) | $ / shares $ 29.37
Vested, number of shares (in shares) | shares (79,205)
Vested, weighted average grant date fair value (in dollars per share) | $ / shares $ 49.99
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Settled in Period | shares 33,834
Settled, weighted average grant date fair value (in dollars per share) | $ / shares $ 30.9
Forfeited, number of shares (in shares) | shares (3,332)
Forfeited, weighted average grant date fair value (in dollars per share) | $ / shares $ 30.9
Unvested, number of shares (in shares) | shares 304,652
Weighted-average exercise price, outstanding (in dollars per share) | $ / shares $ 23.16